SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-22-001455
Filing Date
2022-01-05
Accepted
2022-01-05 16:04:31
Documents
2
Period of Report
2022-01-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2136668-2_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2136668-2_3seq1.xml 3 1599
2 EXHIBIT 24 tm2136668d2_ex24.htm EX-24 7251
  Complete submission text file 0001104659-22-001455.txt   10520
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Issuer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MATINAS BIOPHARMA HOLDINGS, INC. 1545 ROUTE 206 SOUTH, SUITE 302 BEDMINSTER NJ 07921
Business Address
Ende Eric J (Reporting) CIK: 0001494386 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35963 | Film No.: 22511092